Abstract
The central nervous system (CNS) depressant drugs include a variety of medications, such as hypnotics, most antianxiety drugs (also called minor tranquilizers),and alcohol.1 As discussed in greater depth in Section 2.1.1.4.4, a new group of nonbenzodiazepine antianxiety drugs have appeared in recent years, but these are not CNS depressants. The general anesthetics are not presented here, as time and space constraints forced me to limit the discussion to the substances most clinically important in drug abuse. One anesthetic agent, phencyclidine (PCP), is abused as a hallucinogen and is discussed in Chapter 9.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Harvey, S. C. Hypnotics and sedatives. In A. G. Gilman, L. S. Goodman, T. W. Rall, and F. Murad (Eds.), The Pharmacological Basis of Therapeutics ( 7th ed. ). New York: Macmillan, 1985, pp. 339 - 371.
Jaffe, J. H. Drug addiction and drug abuse. In A. G. Gilman, L. S. Goodman, T. W. Rall, and Murad, F. (Eds.), The Pharmacological Basis of Therapeutics ( 7th ed. ). New York: Macmillan, 1985, pp. 532 - 581.
National Clearing House for Drug Abuse Information. The CNS Depressant Withdrawal Syndrome and Its Management: An Annotated Bibliography: 1950-1983. Rockville, Maryland: National Institute on Drug Abuse, 1975.
Sapira, J. D., and Cherubin, C. E. Drug Abuse: A Guide for the Clinician. Amsterdam: Excerpta Medica; New York: American Elsevier, 1975.
Covi, L., Lipman, J. H., Pattison, J. H., et al. Length of treatment with anxiolytic sedatives and response to their sudden withdrawal. Acta Psychiatrica Scandinavica 49: 51 - 64, 1973.
Buston, U., Sellers, E. M., Naranjo, C. A., et al. Withdrawal reaction after long-term therapeutic use of benzodiazepines. New England Journal of Medicine 315: 854 - 859, 1986.
Goodman, W. K., Charney, D. S., Price, L. H., et al. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: Report of three cases. American Journal of Psychiatry 143: 900 - 903, 1986.
Schneider, L. S., Syapin, P. J., and Pawluczyk, S. Seizures following triazolam withdrawal despite benzodiazepine treatment. Journal of Clinical Psychiatry 48: 418 - 419, 1987.
Rickels, K., Case, W. G., Schweizer, E. E., et al. Low-dose dependence in chronic benzodiazepine users: A preliminary report on 119 patients. Psychopharmacology 22: 407 - 416, 1986.
Campbell, R., Schaffer, C. B., and Tupin, J. Catatonia associated with glutethimide withdrawal. Journal of Clinical Psychiatry 44: 32 - 33, 1983.
Falco, M. Methaqualone misuse: Foreign experience and United States drug control policy. International Journal of the Addictions 11: 597 - 610, 1976.
Kay, D. C. Blackburn, A. B., Buckingham, J. A., and Karacan, I. Chapter 4: Human pharmacology of sleep. In R. I. Williams and I. Karacan (Eds.), Pharmacology of Sleep. New York: Wiley, 1976, pp. 419 - 428.
Schuckit, M. A. Anxiety treatment: A commonsense approach. Postgraduate Medicine 75: 52 - 63, 1984.
Raskind, M. A., and Eisdorfer, C. When elderly patients can’t sleep. Drug Therapy, August 1977, pp. 44 - 50.
Dement, W. C. Some Must Watch While Others Sleep: The Portable Stanford. Stanford, California: Stanford Alumni Association, 1972.
Greenblatt, D. J., and Shader, R. I. Benzodiazepines in Clinical Practice. New York: Raven Press, 1974.
Greenblatt, D. J., Harmatz, J. S., Zinny, M. A., and Shader, R. I. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. New England Journal of Medicine 317: 722 - 728, 1987.
Greenblatt, D. J., Shader, R. I., Franke, K., et al. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. Journal of Pharmaceutical Sciences 68: 5763, 1979.
Tallman, J F, Paul, S. M., Skolnick, P., et al. Receptors for the age of anxiety: Pharmacology of the benzodiazepines. Science 207: 274 - 281, 1980.
Darragh, A., Scully, M., Lambe, R., et al. Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15-1788. Lancet 1:8-10,1981.
Massotti, M., Guidotti, A., and Costa, E. Characterization of benzodiazepine and y-aminobutyric acid recognition sites and their endogenous modulators. Journal of Neuroscience 1: 409 - 418, 1981.
Skolnick, P., Moncada, V., Barker, J. L., et al. Pentobarbital: Dual actions to increase brain benzodiazepine receptor affinity. Science 211: 1448 - 1450, 1981.
Britton, K. T., Ehlers, C. L., and Koob, G. F. Is ethanol antagonist Ro 15-4513 selective for ethanol? Science 239: 648 - 649, 1988.
Schuckit, M. A. New frontiers in the treatment of anxiety. Internal Medicine (Special Issue):42-49,1985.
Wheatley, D. Zopiclone: A non-benzodiazepine hypnotic controlled comparison to temazepam in insomnia. British Journal of Psychiatry 146: 312 - 314, 1985.
Rickels, K. Recent advances in anxiolytic therapy. Journal of Clinical Psychiatry 42: 40 - 44, 1981.
Gershon, S., and Eison, A. S. Anxiolytic profiles. Journal of Clinical Psychiatry 44: 45 - 56, 1982
Eison, A. S., and Temple, D. L. Buspirone: Review of its pharmacology and current perspectives on its mechanism of action. American Journal of Medicine 80: 1 - 9, 1986.
Uhlenhuth, E. H. Discussant presentation: Buspirone: A clinical review of a new, non-benzodiazepine anxiolytic. Journal of Clinical Psychiatry 43: 109 - 114, 1982.
Schweizer, E., and Rickels, K. Failure of buspirone to manage benzodiazepine withdrawal. American Journal of Psychiatry 143:1590-1592, 1986.
Riblet, L. A., Taylor, D. P., Eisan, M. S., and Stanton, H. C. Pharmacology and neurochemistry of buspirone. Journal of Clinical Psychiatry 43: 11 - 15, 1982.
Lader, M. Psychological effects of buspirone. Journal of Clinical Psychiatry 43: 62 - 67, 1982.
Moskowitz, H., and Smiley, A. Effects of chronically administered buspirone and diazepam on driving-related skills performance. Journal of Clinical Psychiatry 43: 45 - 49, 1982.
Cole, J. P., Hecht-Orzack, M., Bease, B., and Bird, M. Assessment of the abuse liability of buspirone in recreational sedative users. Journal of Clinical Psychiatry 43: 69, 1982.
Lader, M. Assessing the potential of buspirone dependence or abuse and effects of its withdrawal. American Journal of Medicine 82: 20 - 26, 1987.
Roy-Byrne, P., and Katon, W. An update on treatment of the anxiety disorders. Hospital and Community Psychiatry 38: 835 - 843, 1987.
Mackinnon, G. L., and Parker, W. A. Benzodiazepine withdrawal syndrome: A literature review and evaluation. American Journal of Drug and Alcohol Abuse 9: 19 - 33, 1982.
Busto, U. Patterns of benzodiazepine abuse and dependence. British Journal of Addictions 81: 8794, 1986.
Mellinger, G. D., Baiter, M. B., and Uhlenhuth, E. H. Insomnia and its treatment. Archives of General Psychiatry 42:225-232, 1985.
Chaplin, S. Benzodiazepine prescribing. Lancet 1: 120 - 121, 1988.
Cole, J. O., Haskell, D. S., and Orzack, M. H. Problems with the benzodiazepines: An assessment of the available evidence. McLean Hospital Journal 6: 46 - 74, 1981.
Blackwell, B. Benzodiazepines: Drug abuse and data abuse. Current Psychiatry Research 16: 1037, 1979.
Schuckit, M. Alcohol and drug interactions with antianxiety medications. American Journal of Medicine 82: 27 - 33, 1987
Cohen, S. Valium: Its use and abuse. Drug Abuse and Alcoholism Newsletter 5:1-3, San Diego: Vista Hill Foundation, 1976.
Nicholi, A. M. The nontherapeutic use of psychoactive drugs. New England Journal of Medicine 308: 925 - 933, 1983.
Smart, R. G., Adlaf, E. M., and Goodstadt, M. S. Alcohol and other drug use among Ontario students: An update. Canadian Journal of Public Health 77: 57 - 58, 1986.
Smart, R. G., Goodstadt, M. S., Adlaf, E. M., et al. Trends in the prevalence of alcohol and other drug use among Ontario students: 1977-1983. Canadian Journal of Public Health 76: 157 - 161, 1985.
Brophy, J. J. Suicide attempts with psychotherapeutic drugs. Archives of General Psychiatry 17: 652 - 657, 1967.
Diaz, J. Phenobarbital: Effects of long-term administration on behavior and brain of artifically reared rats. Science 199: 90 - 91, 1978.
Regestein, Q. R., and Reich, P. Agitation observed during treatment with new hypnotic drugs. Journal of Clinical Psychiatry 46: 280 - 283, 1985
Schuckit, M. A., Irwin, M., and Brown, S. The history of anxiety symptoms among 171 primary alcoholics. Journal of Studies on Alcohol (in press).
Lewis, D. C., and Senay, E. C. Treatment of Drug and Alcohol Abuse. New York: Career Teaching Center, 1981.
Setter, J. G. Emergency treatment of acute barbiturate intoxication. In P. G. Bourne (Ed.), A Treatment Manual for Acute Drug Abuse Emergencies. Washington, D.C.: U.S. Government Printing Office, 1974, pp. 49 - 62.
Risch, S. C., Groom, G. P., and Janowsky, D. S. Interfaces of psychopharmacology and cardiology: Part H. Journal of Clinical Psychiatry 42: 47 - 59, 1981.
Diagnosis and Management of Reactions to Drug Abuse. New Rochelle, New York: The Medical Letter, 1977.
Lorch, J. A. Haemoperfusion for acute intoxication with hypnotic drugs. Lancet 1: 1116, 1979.
Allen, M. D., Greenblatt, D. K., and Lacasse, Y. Pharmacokinetic study of lorazepam overdosage. American Journal of Psychiatry 137: 1414 - 1415, 1980.
Boldy, D. A. R., Heath, A., Ruddock, S., Vale, J. A., and Prescott, L. F. Activated charcoal for carbamazepine poisoning. Lancet 1: 1027, 1987.
Editorial: Repeated oral activated charcoal in acute poisoning. Lancet 1:1013-1016,1987.
Nutt, D., and Costello, M. Flumazenil and benzodiazepine withdrawal. Lancet 2: 463, 1987.
Fraser, A. A., and Ingram, I. M. Lorazepam dependence and chronic psychosis. British Journal of Psychiatry 147: 211, 1987.
McLellan, A. T., Woody, G. E., and Brien, C. P. Development of psychiatric illness in drug abusers. New England Journal of Medicine 301: 1310 - 1314, 1979.
Pomara, N., Stanley, B., Block, R., et al. Increased sensitivity of the elderly to the central depressant effects of diazepam. Journal of Clinical Psychiatry 46: 185 - 187, 1985.
Bergman, H., Borg, S., and Holm, L. Neuropsychological impairment and exclusive abuse of sedatives or hypnotics. American Journal of Psychiatry 137: 215 - 217, 1980.
Scharf, M. Comparative amnestic effect of benzodiazepines. Journal of Clinical Psychiatry 49: 134137, 1988.
Raskind, M., and Eisdorfer, C. Psychopharmacology of the aged. In L. L. Simpson (Ed.), Drug Treatment of Mental Disorders. New York: Raven Press, 1976, pp. 123 - 131.
Ashton, H. Benzodiazepine withdrawal: Outcome in 50 patients. British Journal of Psychiatry 82:665-671, 1987.
Rickels, K., Fox, I. L., Greenblatt, D. J., et al. Clorazepate and lorazepam: Clinical improvement and rebound anxiety. American Journal of Psychiatry 145: 312 - 317, 1988.
Jurgens, S. M., and Morse, R. M. Alprazolam dependence in seven patients. American Journal of Psychiatry 145: 625 - 627, 1988.
Fyer, A. J., Liebowitz, M. R., Gorman, J. M., et al. Discontinuation of alprazolam treatment in panic patients. American Journal of Psychiatry 144: 303 - 308, 1987.
Vinogradov, S. Clonidine therapy in withdrawal from high dose alprazolam. American Journal of Psychiatry 143:1188, 1986.
Stewart, R. B., Salem, R. B., Springer, P. K. A case report of lorazepam withdrawal. American Journal of Psychiatry 137: 1113 - 1114, 1980.
Nagy, B. R., and Dillman, C. E. Case report of unusual diazepam abstinence syndrome. American Journal of Psychiatry 138: 694 - 695, 1981.
Preskom, S. H., and Denner, L. J. Benzodiazepines and withdrawal psychosis. Journal of the American Medical Association 237: 36 - 38, 1977.
Wilder, A. Diagnosis and treatment of drug dependence of the barbiturate type. American Journal of Psychiatry 125: 758 - 765, 1968.
Smith, D. E., and Wesson, D. R. Phenobarbital technique for treatment of barbiturate dependence. Archives of General Psychiatry 24: 56-60, 1971.
Diagnosis and Management of Reactions to Drug Abuse,New Rochelle, New York: The Medical Letter, Vol. 19(3), Feb. 1977.
Grant, I., Adams, K. M., and Reed, R. Subacute organic mental disorders. In I. Grant (Ed.), Neuropsychiatric Correlates of Alcoholism. Washington, DC: APA Press, 1986, pp. 37 - 60.
Grant, I., and Judd, L. L. Neuropsychological and EEG disturbances in polydrug users. American Journal of Psychiatry 133 (9): 1039 - 1042, 1976.
Wolkowitz, O. M., Weingartner, H., Thompson, K., and Pickar, D. Diazepam-induced amnesia: A neuropharmacological model of an organic amnestic syndrome. American Journal of Psychiatry 144: 25 - 29, 1987.
Kumar, R., Mac, D. S., Gabrielli, W. F., and Goodwin, D. W. Anxiolytics and memory: A comparison of lorazepam and alprazolam. Journal of Clinical Psychiatry 48: 158 - 160, 1987.
Scharf, M. B. Anterograde amnesia with oral lorazepam. Journal of Clinical Psychiatry 44: 36 2364, 1983.
Ray, W. A., Griffin, M. R., Schaffner, W., et al. Psychotropic drug use and the risk of hip fracture. New England Journal of Medicine 316: 363 - 369, 1987.
Castillo-Ferrando, J. R. Digoxin levels and diazepam. Lancet 2: 368, 1980.
Desmond, P. V., Patwardhan, R. V., Schenker, S., et al. Cimetidine impairs elimination of chlordiazepoxide (Librium) in man. Annals of Internal Medicine 93:266-268, 1980.
Schuckit, M. A. Alcohol and drug interactions with antianxiety medications. American Journal of Medicine 82:27-34, 1987.
Abernethy, D. R., Greenblatt, D. J., Divoli, M., et al. Impairment of diazepam metabolism by low-dose estrogen-containing oral-contraceptive steroids. New England Journal of Medicine 306:791 792, 1982.
Jick, H., Holmes, L. B., Hunter, J. R., et al. First-trimester drug use and congenital disorders. Journal of the American Medical Association 246: 343 - 346, 1981.
Laegried, L. Abnormalities in children exposed to benzodiazepines in utero. Lancet 1: 108 - 109, 1987.
Kellogg, C. K., Simmons, R. D., Miller, R. K., and Ison, J. R. Prenatal exposure in rats: Long-lasting functional changes in the offspring. Neurobehavioral Toxicology and Teratology 7: 483 - 488, 1985.
Gupta, C. Prenatal exposure to phenobarbital permanently decreases testosterone and causes reproductive dysfunction. Science 216: 640 - 642, 1982.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schuckit, M.A. (1989). Central Nervous System (CNS) Depressants. In: Drug and Alcohol Abuse. Critical Issues in Psychiatry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0767-0_2
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0767-0_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0769-4
Online ISBN: 978-1-4757-0767-0
eBook Packages: Springer Book Archive